ENIAC CSI
Central Nervous System Imaging
Contract No. 120209
• FP7 – ENIAC joint call
www.eniac-csi.org
• Start: 1 Mar 2010
• Duration
36 months
+8 months extension
• Consortium
14 partners
from 4 countries
Netherlands
Austria
Italy
Hungary
14 partners
•
Big industries
–
–
–
–
•
Small and medium enterprises
–
–
•
Guger Technologies OEG (AT)
Mat-Tech (NL)
Research institutes
–
–
–
–
–
–
–
•
STMicroelectronics (IT) → Leader of the consortium
Philips Applied Technologies (NL)
Philips Healthcare (NL)
AustriaMicroSystems (AT)
University of Bologna (IT)
Politecnico di Torino (IT)
IMEC (NL)
Austrian Institute of Technology (AT)
MTA Atomki (HU) → Leader of the Hungarian consortium
University of Debrecen (HU)
University of Pannonia (HU)
Clinics
–
Kempenhaeghe (NL)
•
Concept
–
The unavoidable process of aging of the European
population demands for a comprehensive technology
support to the diagnostic and therapy
of central nervous system diseases.
–
These serious illnesses call for the most expensive
diagnosis/therapy procedures in the western countries
(sometimes more expensive than cardiologic diseases).
–
Furthermore, central nervous system’s diseases are
among those with the fastest growing impact on society.
They include degenerative brain diseases ranging from
Alzheimer and Parkinson to circulatory problems
including strokes.
–
Minimally-invasive imaging technologies based on
Information Communications Technology such as
PET (Positron Emission Tomography),
MRI (Magnetic Resonance Imaging) and
EEG (Electro EncephaloGram)
allow for monitoring and tracking the evolution of these
illnesses starting from their preliminary setting and
determining the strategy and the effectiveness of the
prescribed therapies.
•
Objectives
–
Simultaneous capturing/extraction of data produced by
new generation’s imaging devices, in order to provide
the best correlated information to the physician through
an innovative and intelligent merging both in timing (i.e.
EEG) and spatial resolution (i.e. PET).
–
This combined and synergistic approach can only be
made possible through advances in various technology
fields that include sensors, integrated equipments and
systems for data fusion and novel data processing
platforms that support Teraflop-range computing
capability right at the doctor’s desktop. As a whole the
project will anticipate new perspectives to improve
patient’s support and treatment for central nervous
system’s diseases, at much lower cost.
–
In line with ENIAC’s market timeline, this project will
address some of the most appealing downstream
technologies for 3D Functional Brain Imaging, yet
focusing on realistic enhancement and super-integration,
so to achieve higher quality delivery while reducing the
overall cost of patient management.
Small animal PET scanners
• MiniPET-2
with conventional PM tubes
• MiniPET-3
with SiPMs
MRI compatibility
Parkinson
Alzheimer
Epilepsy